Advertisement
Hydroxycitrate

Hydroxycitrate Promising for Kidney Stone Prevention

0
Researchers suggest it might offer alternative to current treatment that has side effects
For certain patients with metastatic renal cell carcinoma

Active Surveillance Prior to Systemic Tx Feasible in Renal CA

0
Shorter surveillance period for those with more IMDC adverse risk factors, more metastatic disease sites
Since the early 2000s there has been little increase in the prevalence of stage 3 and 4 chronic kidney disease in the United States

No Recent Increase in Prevalence of Chronic Kidney Disease in U.S.

0
Since early 2000s, little increase in prevalence of stage 3 and 4 chronic kidney disease
Tumor cell-intrinsic metabolic factors may contribute to anti-programmed death 1 (PD-1)/PD-L1 treatment resistance in renal cell carcinoma

Metabolic Factors May Contribute to Tx Resistance in Renal Cancer

0
Genes involved in metabolic and solute transport function linked to treatment failure in PD-L1+ RCC
Among adults with septic shock

Vasopressin Doesn’t Cut Kidney Failure-Free Days in Septic Shock

0
No improvement in kidney failure-free days versus norepinephrine in adults with septic shock
Low abundance biomarker panels can predict lupus nephritis outcomes

Urinary Biomarkers Can Predict Response in Lupus Nephritis

0
Models created with traditional + novel biomarkers have clinically meaningful predictive power

July 2016 Briefing – Nephrology

0
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for July 2016. This roundup includes the latest...
European health systems are requiring an increase in cost-sharing measures for patients 50 years of age and older

European Countries Implementing Cost-Sharing

0
Some financial protections are in place for poorer populations
In an experimental study published online July 27 in the Journal of the American Heart Association

Marijuana May Cause More Damage to Heart Than Tobacco

0
Exposure impaired endothelial function in rats for at least 90 minutes
The U.S. Food and Drug Administration announced Tuesday that it's strengthening label warnings on fluoroquinolones because the drugs can lead to disabling side effects

FDA Strengthens Safety Warnings for Fluoroquinolones

0
Fluoroquinolones such as Cipro, Levaquin should be reserved for life-threatening infections